Asset Details
Do you wish to reserve the book?
Uncovering multi-target natural inhibitors for hypertension through network pharmacology and structure-based screening
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Uncovering multi-target natural inhibitors for hypertension through network pharmacology and structure-based screening
Do you wish to request the book?
Uncovering multi-target natural inhibitors for hypertension through network pharmacology and structure-based screening
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Uncovering multi-target natural inhibitors for hypertension through network pharmacology and structure-based screening
2026
Overview
Hypertension is a major global health challenge and a key risk factor for cardiovascular, renal, and cerebrovascular disorders. Despite the availability of several synthetic antihypertensive drugs, their prolonged use often leads to adverse side effects, underscoring the need for safer alternatives. Natural compounds represent a promising source of bioactive molecules with potential therapeutic efficacy. Given the multifactorial nature of hypertension, multi-target therapeutic strategies may offer improved disease management. This study employed an integrative computational approach combining network pharmacology and structure-based analyses to identify potential protein targets and natural compounds relevant to hypertension. A total of 22 protein targets associated with hypertension-related pathways were identified. Virtual screening and pharmacokinetic (ADME) evaluations revealed 16 phytochemicals with strong binding affinities, among which 10 exhibited favorable drug-likeness and multi-target interaction profiles. Overall, the findings highlight several natural compounds as promising antihypertensive candidates with polypharmacological potential and a lower likelihood of adverse effects compared to conventional drugs. Experimental validation of the identified targets and lead compounds is warranted to confirm their therapeutic efficacy.
Publisher
International Academy of Ecology and Environmental Sciences (IAEES),International Academy of Ecology and Environmental Sciences
Subject
/ Proteins
